_DSC9935_byn.jpg

The Creator of Sulfagenix

Gabriel Gojon Sr., Ph.D.

Chief Scientific Officer

Co-Founder

The Creator of Sulfagenix

Leadership in Sodium Polysulthionate Research

Chief Scientific Officer and co-founder of Sulfagenix Gabriel Gojón Sr., Ph.D., is the co-discoverer of SG1002. He is an expert in free-radical chemistry and sodium polysulthionate research and was awarded the 2007 Andrés Manuel del Rio prize from the National Chemical Society Mexico, honoring him as the best chemistry scientist in the country.

ACADEMIC BACKGROUND

1973

1961

​Ph. D.(physical-organic chemistry) , Louisiana State University.

B.Sc. in chemistry,  ITESM, Monterrey, N.L., México.

2011 - 2016  

2007 - 2010

PROFESSIONAL EXPERIENCE

2017 - 

1998-2006

1996 - 1997

1995

1984 - 1995

1977 - 1983

1976 - 1977

1973 - 1976

1974 - 1975

1967 - 1970

1964 - 1966

Chief Scientific Officer , Sulfagenix Inc

Chief Technical Officer, Sulfagenix Inc

Head of R&D Department, NAN Laboratorios.

Monterrey, N.L., México.

Head of R&D Department , Reactimex S.A. de C.V.

Monterrey, N.L., México.

Professor, UDLA-PUEBLA.

Cholula, Mexico

Visiting professor, UDLA-PUEBLA.

Cholula, Mexico

Research Professor, UANL Facultad de Química, División de Estudios Superiores.

Monterrey N.L., Mexico

Director of División of Engineering and Exact Sciences, Universidad Regiomontana.

Monterrey, N.L., México

Program Coordinator and Department Head, Centro de Investigación en Química Aplicada (CIQA).

Saltillo, Coahuila, México.

Associate Research Professor, CINVESTAV, Zacatenco.

Mexico City, México.

Visiting Professor, Universidad Autónoma de Puebla.

Puebla, México.

Professor, Department of Chemistry, ITESM.

Monterrey, N.L., México.

Full-time Instructor, Universidad Labastida.

Monterrey, N.L., México.

RESEARCH EXPERIENCE AT THE ACADEMIC-INDUSTRIAL INTERFACE

2010

2009

2007

2006

2005

Synthesis of hydrogen sulfide prodrugs to be tested in vivo

Emory University School of Medicine

M. Sc thesis advisor of Isis Carrillo

NAN Laboratorios/ITESM

B. Sc. thesis advisor of Alma Delia Huerta

NAN Laboratorios/ITESM/CONACYT

B. Sc. thesis advisor of  Catalina Beltrán and Isis Carrillo

Reactimex/ITESM/CONACYT

B. Sc. thesis advisor of Paulina Concha and Jesús A. Salazar

Reactimex/ITESM/CONACYT

1998

1995

1995

BASIC RESEARCH EXPERIENCE

1978 - 2005

Coordination of 32 thesis projects

20  MSc and  12 BSc

Principal Investigator of  Proyecto de Riesgo Compartido

CONACYT - Productos Químicos de Chihuahua - Universidad Regiomontana

M.Sc. thesis advisor of Felipa A. Treviño

INDUSTRIAL NEPTUNO/ UANL

Coordination of Research  Projects contemplated

Facultad de Química UANL -HYLSA S.A. de C.V. Research Agreement.

M.Sc thesis advisor of Myriam Montante

Reactimex/UANL

Coordination of Projects contemplated

Facultad de Química UANL – GRUPO CYDSA Research Agreement.

Coordination of Projects contemplated

Facultad de Química UANL-PYOSA S.A. de C.V. Research Agreement.

B. Sc. thesis advisor of  Ivonne Ramones

Reactimex/ITESM

1978 - 1980

1983 - 1984

1985 - 1988

1991 - 1992

1988 - 1995

CONSULTING EXPERIENCE

2008 - 2010

2006

2002 - 2005

2001 - 2015

1985 - 1997

1981 - 1984, 1996

1988 - 1992

1989 - 1990

1982 - 1983

1980 - 1982

GRUPO PETROQUÍMICO IDESA

Coatzacoalcos , Mexico

REACTIMEX SA de CV

Monterrey, N.L. Mexico

ALUWE LLC

Minnetonka, MN USA

PYOSA, SA de CV

Monterrey, N.L., Mexico

GRUPO CYDSA, S.A. DE C.V

Dirección Corporativa de Tecnologías y Mejoramiento Ambiental, Mty. NL Mexico 

PRODUCTOS DESHIDRATADOS DE MEXICO (PRODEMEX), S.A. de C.V.

Los Mochis, Sin. , Mexico

PROTEXA, S.A. de C.V.

Depto. de Investigación y Desarrollo, Monterrey, N.L.Mexico

HYLSA, S.A. de C.V.

Depto. de Investigación y Desarrollo, Monterrey, N.L.Mexico

ENZYMOLOGA, S.A.

Monterrey, N.L. Mexico

PRODUCTOS QUIMICOS DE CHIHUAHUA, S.A.

Chihuahua, Chih. , Mexico

EXPERIENCE IN TECHNOLOGY TRANSFER

2014

2013

2002

2001

Technology for the synthesis of SG-1002 ( a hydrogen sulfide prodrug )

transferred from NAN Laboratorios/Sulfagenix Inc. to IDT - Australia.

Technology for the synthesis of SG1002

transferred from NAN-Sulfagenix Inc. to Reactimex S.A. de C.V. (Monterrey, N.L., Mexico)

Seven  multistage organic  synthetic processes

transferred from ROCHE- SYNTEX to Reactimex S.A. de C.V.

One multistage organic synthetic process

transferred from COLORCHEM to Reactimex S.A. de C.V.

DESIGN OF EXTENSION COURSES

  • Experimental Optimization of Processes and  Formulations

for research staff of PYOSA and Conductores Monterrey

PATENTS

  • Gójon-Zorrilla, G; Gójon-Romanillos, G.  “Preparation and compositions of zero-valent sulphur having high bioavailability, and uses thereof” US8771755 B2, (Julio 08, 2014)

  • Gójon-Zorrilla, G; Gójon-Romanillos, G.  “Preparation and compositions of zero-valent sulphur having high bioavailability, and uses thereof” WO2013055199A1, (Abril 18, 2013)

 

  • Gójon-Zorrilla, G et al, “Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof”, WO2013040240, (Marzo 21, 2013) 

 

  • Gójon-Zorrilla, G; Gójon-Romanillos, G.  “Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof”,  US20130064904A1, (Marzo 14, 2013)

  • Gojon-Zorrilla G; Gojon-Romanillos G, ““Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof”, HONG KONG 15100731.7 (January 26 2015).

 

  • Gojon-Zorrilla G; Gojon-Romanillos G, “Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof”, CN201280055643.5 (September 28, 2016) 

 

  • Gojon-Zorrilla G; et al, “preparation et composition de soufre de valence zero a biodesponibilité elevée et leurs utilisations, EP2755478 (julay 23, 2014)

 

  • Gojon-Zorrilla G; Gojon-Romanillos G, “Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof”, EMX/a/2014/003289 (march 13, 2014)

 

  • Gojon-Zorrilla G; Gojon-Romanillos G, “Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof”, JP 5992525 (august 26, 2016)

 

  • Gojon-Zorrilla G; Gojon-Romanillos G, “Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof”, CA 2847589 (April 18, 2013)

 

  • Gojon-Zorrilla G; Gojon-Romanillos G, “Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof”, VR 112014005144-5 (September 13, 2012)

 

  • Gojon-Zorrilla G; Gojon-Romanillos G, “Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof”, AU 2012321444 (September 24, 2015)

 

  • Gojon-Zorrilla Gabriel ; Gojon-Romanillos Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes”, PCT/US2015/039075

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos, Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes”, MX2017000222

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or or treating or preventing the development of diabetes”, IN201747003247

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos, Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming or treating or preventing the development of diabetes, EP15815585

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming or treating or preventing the development of diabetes”, CN112015000047257

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos Gabriel, “ Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes “, US14790824

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes”, RU2017103450

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes “, CA2954004

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes”, JP2017523158

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes”, AU2015283905

 

  • Gojon-Zorrilla Gabriel, Gojon-Romanillos Gabriel, “Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes”, PE04702017

 

  • Gojon Gabriel, “Method for the synthesis of amides and related products from esters or ester-like compounds”, US2005-0027120

 

  • Gojon Gabriel, “Oxidative dehalogenation process for chloranil production”, US5329027 (1994)

USA Address

3561 E Sunrise Dr, Ste 131

Tucson Arizona, USA 85718

Mexico Address

Av. Ricardo Margain 440, Torre Sofía Of. 602

San Pedro Garza García, Nuevo León, Mexico 66265

Terms

Privacy

CONFIDENTIAL INFORMATION: Contains information that is confidential, proprietary copyrighted and/or legally privileged, and protected from disclosure. | SULFAGENIX INC 2020